2022
DOI: 10.1111/ppe.12896
|View full text |Cite
|
Sign up to set email alerts
|

Comparing adverse neonatal and maternal outcomes of chlamydia, gonorrhoea, and syphilis infections and co‐infections in pregnancy

Abstract: Background While maternal sexually transmitted infections (STIs) during pregnancy have been extensively studied, fewer studies have directly compared the associations of different infections and co‐infections or investigated the association between STIs in pregnancy and maternal outcomes. Objectives We examine associations between STIs and co‐infections in pregnancy on risks of adverse neonatal and maternal outcomes. Methods Data from the 2019 US natality files (n = 3,747,882) were used to assess the associati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 25 publications
1
6
0
Order By: Relevance
“…The authors show that in many cases, universal screening results in unnecessary antibiotic use for the prevention of GBS—important for tailoring our screening measures. Despite longstanding screening guidelines in the United States for sexually transmitted infections, Felske and colleagues 13 show that 2% of live births in 2019 occurred to pregnant persons with a chlamydia, gonorrhoea or syphilis infection and 0.2% were a combination of these infections (co‐infection). The resurgence of congenital syphilis over the past decade in the United States and increasing state‐wide outbreaks calls for enhanced preventive efforts and broader screening measures to better support maternal, foetal and neonatal health.…”
Section: Application To Maternal and Infant Health Promotionmentioning
confidence: 99%
“…The authors show that in many cases, universal screening results in unnecessary antibiotic use for the prevention of GBS—important for tailoring our screening measures. Despite longstanding screening guidelines in the United States for sexually transmitted infections, Felske and colleagues 13 show that 2% of live births in 2019 occurred to pregnant persons with a chlamydia, gonorrhoea or syphilis infection and 0.2% were a combination of these infections (co‐infection). The resurgence of congenital syphilis over the past decade in the United States and increasing state‐wide outbreaks calls for enhanced preventive efforts and broader screening measures to better support maternal, foetal and neonatal health.…”
Section: Application To Maternal and Infant Health Promotionmentioning
confidence: 99%
“…A recent meta-analysis [ 13 ] suggests a moderate association between gonorrhea and preterm birth, preterm premature rupture of membranes (pPROM), and perinatal mortality, but most of these studies did not include multivariable analyses, and they were limited by low screening rates in the target population. In recent studies, chlamydia and syphilis have been linked to hypertensive disorders of pregnancy (HDP) [ 14–17 ], which include a spectrum of disorders (gestational hypertension, preeclampsia, and superimposed preeclampsia) [ 18 ]. Preeclampsia, the new onset of hypertension and systemic organ dysfunction, is an HDP that imposes a great risk of maternal mortality and morbidity [ 19 ].…”
mentioning
confidence: 99%
“…Preeclampsia is distinguishable from superimposed preeclampsia, which occurs among individuals entering pregnancy with chronic hypertension, and gestational hypertension, which does not result in multiple organ dysfunction. Chlamydia has been associated with superimposed preeclampsia and preeclampsia with severe features, whereas syphilis has been associated with gestational hypertension [ 14–17 ]. Studies of gonorrhea and HDP are rare [ 14 , 15 ], and it remains unknown whether gonorrhea has any impact on various HDP.…”
mentioning
confidence: 99%
See 2 more Smart Citations